Melanie Demes

594 total citations
30 papers, 311 citations indexed

About

Melanie Demes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Melanie Demes has authored 30 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Melanie Demes's work include Lung Cancer Research Studies (6 papers), Colorectal and Anal Carcinomas (5 papers) and Genital Health and Disease (5 papers). Melanie Demes is often cited by papers focused on Lung Cancer Research Studies (6 papers), Colorectal and Anal Carcinomas (5 papers) and Genital Health and Disease (5 papers). Melanie Demes collaborates with scholars based in Germany, United Kingdom and United States. Melanie Demes's co-authors include Annette Fisseler‐Eckhoff, Peter J. Wild, Holger Bartsch, J. Schirren, Jörg Trojan, Katrin Bankov, Christine Koch, Ivan Jelas, Sebastian Stintzing and Paul K. Ziegler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Melanie Demes

23 papers receiving 305 citations

Peers

Melanie Demes
Melanie Demes
Citations per year, relative to Melanie Demes Melanie Demes (= 1×) peers Orhun Çığ Taşkın

Countries citing papers authored by Melanie Demes

Since Specialization
Citations

This map shows the geographic impact of Melanie Demes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Demes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Demes more than expected).

Fields of papers citing papers by Melanie Demes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Demes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Demes. The network helps show where Melanie Demes may publish in the future.

Co-authorship network of co-authors of Melanie Demes

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Demes. A scholar is included among the top collaborators of Melanie Demes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Demes. Melanie Demes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alborelli, Ilaria, Melanie Demes, Peter J. Wild, et al.. (2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. SHILAP Revista de lepidopterología. 6(3). 19–19.
2.
Straßheimer, F, Jadranka Macas, Tijna Alekseeva, et al.. (2025). CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma. British Journal of Cancer. 132(9). 849–860. 6 indexed citations
3.
Winkelmann, Ria, Nina I. Becker, Peter J. Wild, et al.. (2024). Gene Expression Profiling of the Peritumoral Immune Cell Infiltrate of Penile Squamous Cell Carcinomas. International Journal of Molecular Sciences. 25(22). 12142–12142.
4.
Schulze, Falko, Christina Schmitt, Fabian Finkelmeier, et al.. (2024). Heterogeneity of small duct‐ and large duct‐type intrahepatic cholangiocarcinoma. Histopathology. 84(6). 1061–1067. 5 indexed citations
6.
Demes, Melanie, Yannick Braun, Elise Gradhand, et al.. (2023). Increased MCL1 dependency leads to new applications of BH3-mimetics in drug-resistant neuroblastoma. British Journal of Cancer. 129(10). 1667–1678. 9 indexed citations
7.
Himmelsbach, Vera, Christine Koch, Fabian Finkelmeier, et al.. (2023). Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center. Journal of Cancer Research and Clinical Oncology. 149(9). 6391–6398. 4 indexed citations
8.
Klasen, Christian, Vera Himmelsbach, Christine Koch, et al.. (2023). Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center. Zeitschrift für Gastroenterologie. 61(8). e497–e497.
9.
Visonà, Giovanni, Elke Hattingen, Thomas J. Vogl, et al.. (2023). Machine-Learning-Aided Prediction of Brain Metastases Development in Non–Small-Cell Lung Cancers. Clinical Lung Cancer. 24(8). e311–e322. 8 indexed citations
11.
Bankov, Katrin, Jens von der Grün, Natalie Filmann, et al.. (2022). Tumor-associated immune cell infiltrate density in penile squamous cell carcinomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(6). 1159–1169. 10 indexed citations
12.
Winkelmann, Ria, Katrin Bankov, Jens von der Grün, et al.. (2022). The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods. BMC Urology. 22(1). 10–10.
13.
Winkelmann, Ria, Katrin Bankov, Claudia Döring, et al.. (2022). Increased HRD score in cisplatin resistant penile cancer cells. BMC Cancer. 22(1). 1352–1352. 3 indexed citations
14.
Reis, Henning, et al.. (2022). State of the Art: onkogen alteriertes nichtkleinzelliges Lungenkarzinom im Stadium IV. 28(12). 1087–1094. 1 indexed citations
15.
Müller, Tina, Melanie Demes, Jens Köllermann, et al.. (2021). The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis. Clinical & Translational Oncology. 24(2). 331–341. 9 indexed citations
16.
Trojan, Jörg, Sebastian Stintzing, Oliver Haase, et al.. (2021). Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer. The Oncologist. 26(12). e2110–e2114. 37 indexed citations
17.
Oehl, Kathrin, Bart Vrugt, Ulrich Wagner, et al.. (2021). Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma. Clinical Cancer Research. 27(8). 2277–2291. 30 indexed citations
18.
Weichert, Wilko, Stephan Bartels, Gustavo Baretton, et al.. (2021). 758P Concordance between multiple HRD assays is substantial in high-grade ovarian cancer. Annals of Oncology. 32. S747–S747. 1 indexed citations
19.
Demes, Melanie, et al.. (2016). Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung. Cancers. 8(4). 38–38. 24 indexed citations
20.
Bölükbas, Servet, et al.. (2012). Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery. 44(1). 119–123. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026